Individualized insulin therapy in children and adolescents with type 1 diabetes

被引:11
作者
Becker, D [1 ]
机构
[1] Childrens Hosp Pittsburgh, Dept Pediat, Div Endocrinol Metab & Diabet Mellitus, Pittsburgh, PA 15213 USA
关键词
cultural differences; insulin absorption; insulin analogues; insulin delivery systems; insulin preparations;
D O I
10.1080/080352598750030555
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The most important point about individualized therapy is to make it flexible to fit the needs of the patient. These needs are determined by age, pubertal status, treatment schedule, exercise, intelligence, education and socioeconomic status. In addition, major emphasis should be placed on the dietary needs, attitude and ability of the patient. Aspects of insulin regimens that can be adjusted include number of injections per day, timing of injections and the type of insulin used. Several factors that affect insulin action should also be considered, including the presence of insulin antibodies, the amount of subcutaneous fat, injection technique and muscular activity. Insulin pump therapy in childhood and adolescence may also be considered in certain cases. Controversial areas in childhood diabetes therapy include the number of daily injections, whether porcine insulin has any advantages, use of multiple doses of intermediate- and long-acting insulin, mixing regular insulin and short-acting insulin analogues, strategies to prevent hypoglycaemia and the importance of choice of injection sites in childhood.
引用
收藏
页码:20 / 24
页数:5
相关论文
共 15 条
[1]   Insulin analogues [J].
Barnett, AH ;
Owens, DR .
LANCET, 1997, 349 (9044) :47-51
[2]   INSULIN PHARMACOKINETICS [J].
BINDER, C ;
LAURITZEN, T ;
FABER, O ;
PRAMMING, S .
DIABETES CARE, 1984, 7 (02) :188-199
[3]   Prolonged efficacy of short acting insulin Lispro combination with human ultralente in insulin-dependent diabetes mellitus [J].
Burge, MR ;
Waters, DL ;
Holcombe, JH ;
Schade, DS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (03) :920-924
[4]   Meal composition is a determinant of lispro-induced hypoglycemia in IDDM [J].
Burge, MR ;
Castillo, KR ;
Schade, DS .
DIABETES CARE, 1997, 20 (02) :152-155
[5]   INCREASED INSULIN-SECRETION IN PUBERTY - A COMPENSATORY RESPONSE TO REDUCTIONS IN INSULIN SENSITIVITY [J].
CAPRIO, S ;
PLEWE, G ;
DIAMOND, MP ;
SIMONSON, DC ;
BOULWARE, SD ;
SHERWIN, RS ;
TAMBORLANE, WV .
JOURNAL OF PEDIATRICS, 1989, 114 (06) :963-967
[6]  
DRASH A, 1987, CLIN CARE DIABETIC C
[7]   Strategies toward improved control during insulin lispro therapy in IDDM - Importance of basal insulin [J].
Ebeling, P ;
Jansson, PA ;
Smith, U ;
Lalli, C ;
Bolli, GB ;
Koivisto, VA .
DIABETES CARE, 1997, 20 (08) :1287-1289
[8]  
ECKENRODE KL, 1986, DIABETES S1, V35, P118
[9]   Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin [J].
Fineberg, NS ;
Fineberg, SE ;
Anderson, JH ;
Birkett, MA ;
Gibson, RG ;
Hufferd, S .
DIABETES, 1996, 45 (12) :1750-1754
[10]   Drug therapy - Insulin lispro [J].
Holleman, F ;
Hoekstra, JBL .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (03) :176-183